Phase 2 trial findings support empagliflozin use in patients without diabetes for calcium and uric acid stone prevention. Empagliflozin use can reduce the risk of calcium and uric acid kidney stones ...

Finerenone treatment vs placebo was associated with a reduced risk for new-onset diabetes by 24% among patients with HFmrEF or HFpEF.

Treatment with romosozumab led to improvements in bone microarchitecture among postmenopausal women with osteoporosis.

Gastrointestinal adverse events partially mediated the weight loss effects among patients with obesity who received tirzepatide vs placebo.

In an extended follow-up study, intensive blood pressure control is associated with reductions in the rate of cognitive impairment.

The severity of left ventricular diastolic dysfunction affects risk for incident stroke and transient ischemic attack, as well as major bleeding.

With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...

Use of long-acting, reversible contraceptives is associated with an increased risk of certain cancers, a study suggests.

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...

GLP-1RAs were not associated with an increased risk for thyroid cancer relative to DPP-4 inhibitor use among an international cohort.

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

A scientific statement regarding nursing wellness in cardiovascular and stroke care has been published by the American Heart Association.